Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Hautklinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Staubach-Renz, P.

Mr. Pharmacist Dr. Gerd Wolf, has works published, Pharmacist

HAUTARZT. Bd. 66. H. 1. 2015 S. 77-77


Clausen, Bjoern E.; Grabbe, Stephan

Multifaceted Contributions of Epidermal Langerhans Cells to Cutaneous Carcinogenesis

JOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 135. H. 5. 2015 S. 1218-1220


Ochsendorf, F.; Bandholz, T.; Emmert, S. et al.

New catalog of Learning Objectives Dermatology of the Forum Academic teaching: Consensus on Basic Skills

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 111-111


Staubach, P.; Metz, M.; Chapman-Rothe, N. et al.

Omalizumab leads to a significant Reduction of Angioedema-Episodes in Patients with chronic spontaneous Urticaria

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 86-87


Zimmer, Lisa; Eigentler, Thomas K.; Kiecker, Felix et al.

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

JOURNAL OF TRANSLATIONAL MEDICINE. Bd. 13. 2015


Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard et al.

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

LANCET ONCOLOGY. Bd. 16. H. 8. 2015 S. 908-918


Zuraw, B. L.; Cicardi, M.; Longhurst, H. J. et al.

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate

ALLERGY. Bd. 70. H. 10. 2015 S. 1319-1328


Krebs, F.; Uenal, Oe; Hahn, S. A. et al.

Phenotypical changes of melanoma cells and T cell subsets providing a loophole for relapse in Vemurafenib therapy

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 32-32


Tappertzhofen, Kristof; Weiser, Franziska; Montermann, Evelyn et al.

Poly-L-Lysine-Poly[HPMA] Block Copolymers Obtained by RAFT Polymerization as Polyplex-Transfection Reagents with Minimal Toxicity

MACROMOLECULAR BIOSCIENCE. Bd. 15. H. 8. 2015 S. 1159-1173


Foerster, F.; Kaps, L.; Brose, A. et al.

PRECLINICAL EVALUATION OF DEXTRAN-BASED THERAPEUTIC NANOPARTICLES FOR HEPATIC DRUG DELIVERY

JOURNAL OF HEPATOLOGY. Bd. 62. 2015 S. S426-S426